Sort   by:  
 Page size 
Genome-wide CRISPR screening on cytotoxic T lymphocytes mediated cell killing independent of Casp3
Most triple-negative breast cancer (TNBC) patients fail to respond to T cell-mediated immunotherapies. Unfortunately, the molecular determinants are still poorly understood. Breast cancer is the disease genetically linked to a deficiency in autophagy. Here, we show that autophagy promotes tumour imm...
ORGANISM(S): Homo sapiens (Human) 
2020-08-05 | PXD019946 | Pride
Most triple-negative breast cancer (TNBC) patients fail to respond to T cell-mediated immunotherapies. Unfortunately, the molecular determinants are still poorly understood. Breast cancer is the disease genetically linked to a deficiency in autophagy. Here, we show that autophagy promotes tumour imm...
ORGANISM(S): Mus musculus (Mouse) 
2020-08-05 | PXD019947 | Pride
RNAseq profilling of monocytes co-cultured with HIV-TYBE infected primary CD4 T cells (E:T=10:1) in the presence of 10-1074, 10-1074-SiaD or Isotype antibody
ORGANISM(S): Homo sapiens 
Genome-wide CRISPR screening on cytotoxic T lymphocytes mediated cell killing independent of Casp3, Mlkl, and Bid
Resistance to immune cell-mediated cytotoxicity poses a significant challenge in cancer therapy, compromising the efficacy of immunotherapeutic approaches such as immune checkpoint blockade (ICB) treatment. To enhance therapy outcomes, it is crucial to identify interventions that can synergize with ...
ORGANISM(S): Homo sapiens (Human) 
2025-12-08 | PXD062987 | Pride
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
A Major Chromatin Regulator Determines Resistance of Tumor Cells to T cell Mediated Killing
CUL5 E3 ubiquitin ligase regulates the evasion of bladder cancer cells to CD8+ T cell-mediated killing by inhibiting autophagy
TSC2 regulates tumor susceptibility to TRAIL-mediated T cell killing by orchestrating mTOR signaling
Sort   by:  
 Page size